A pilot study on the clinical effect of probiotics "Yasainosenshi" among patients with mild to moderate ulcerative colitis.

A pilot study on the clinical effect of probiotics "Yasainosenshi" among patients with mild to moderate ulcerative colitis. - Efficacy of probiotics "Yasainosenshi" among ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019753

Enrollment

Registered

2015-11-11

Start date

2015-11-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Administration of probiotics &quot

Yasainosenshi&quot

for 8 weeks After 8 weeks of observation, administration of probiotics &quot

for 8 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulcerative colitis Mild to moderate disease activity Constant symptom for 4 weeks

Exclusion criteria

Exclusion criteria: Cytapheresis therapy Concomitant antibiotics Pregnant women

Design outcomes

Primary

Measure	Time frame
Improvement rate of clinical activity (Rachmilewitz's CAI)	—

Countries

Japan

Contacts

Public ContactShigeki Bamba

Shiga University of Medical Science Division of Gastroenterology

sb@belle.shiga-med.ac.jp077-548-2217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

A pilot study on the clinical effect of probiotics &quot;Yasainosenshi&quot; among patients with mild to moderate ulcerative colitis.